News

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed...

On July 8, 2024, the United States FDA revised its draft guidance on tackling misinformation about medical devices and prescription drugs, providing a Q&A format for the industry. These updated suggestions offer various approaches for companies with FDA-approved or...

The pharmaceutical sector significantly impacts global and regional economies, continually evolving through various industry trends. Packaging plays a vital role in this sector. Currently, the packaging ensures patient safety by providing essential product information, tamper resistance, and traceability. Pharmaceutical packaging...

The pharmaceutical sector is poised for notable expansion thanks to innovations in gene therapy and GLP-1 medications, but it confronts several formidable challenges, including the expiration of patents, unpredictable funding, and pricing constraints. In the midst of these issues, sustainability...

The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors can develop Diversity Action Plans to ensure trial participants better reflect the populations that will...

The worldwide demand for biodegradable pharmaceutical packaging is set for significant growth. As per  the forecast the market size will rise dramatically from USD 83.46 billion in 2023 to almost USD 335.82 billion by 2032. This surge, with a...

Biomedical waste is a serious matter. Hospitals, clinics, and labs produce tons of it daily. Throwing it out carelessly can harm people and the environment. This healthcare waste includes a wide range of potentially hazardous materials, from used syringes...